Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells.
about
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.Pathogenesis of human immunodeficiency virus infectionT lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Antibody-Dependent Enhancement of Hepatitis C Virus InfectionV1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infectionCorrelations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development.Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1.Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashionEnhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clonesA "complement-ary" AIDS vaccine.Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV.Antibody mediated enhancement of HIV-1 infection of an EBV transformed B cell line is CD4 dependent.Mechanisms of opsonized HIV entry in normal B lymphocytes.
P2860
Q24538755-A01AB20A-221B-4F15-8F1B-6526E404D3F6Q24634681-3170011B-E203-4FAB-9661-7DC625EF7160Q24672100-F5970452-A9E8-4F0E-A315-9EFD2D72C563Q24675546-99BED06B-52ED-4885-B109-127ACD502A99Q27485451-41221723-D6DC-4EE8-BE2B-4FF2A0919C74Q33874253-1C13D1E8-264A-4D61-8DF2-F0841A2064B6Q34009510-4815648B-8A84-4C68-ACE6-125581EA307DQ35174403-FB86160B-DE1B-46BA-93D9-4E3D14E69CF2Q35829627-209CC0E2-3689-492F-9E82-BE35DCA26C0DQ36230054-68D49E74-FA05-470C-85B9-69E9552B9CD9Q36230737-6D4355C2-136A-4068-A11F-5B45CFB3149CQ36366046-01C3093B-436C-4CF3-BA64-05DD659235E4Q36822254-26C24508-21BE-49B8-9F2B-4989CFBD497EQ40953980-B7CBBBBF-6B9E-418F-A2D3-1D067296D398Q41536475-54208958-C1B3-4AA7-ADB0-96E90B463864Q41593439-F98E184D-D1A7-4BA5-894F-0263A2764181Q41599750-AA4ED8EA-5B02-4797-B7E4-577E6B79CFD8Q43542038-0D977DF7-1199-4BBC-ACD5-611C457E7A1D
P2860
Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@ast
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@en
type
label
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@ast
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@en
prefLabel
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@ast
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@en
P2093
P2860
P356
P1476
Complement receptor 2 mediates ...... n-Barr virus-carrying B cells.
@en
P2093
Tremblay M
Wainberg MA
P2860
P304
P356
10.1084/JEM.171.5.1791
P407
P577
1990-05-01T00:00:00Z